⌕
GE HealthCare Technologies · GEHC · Nasdaq
Tenet 45 · Mixed
Compare
$81.84−1.35%At closeTenet 45 · Mixed
$81.84−1.12 (−1.35%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$81.99+0.15 (+0.18%)
After hours: Nov 17, 2026, 7:27 PM ET

GE HealthCare Technologies (GEHC) Earnings Forecast

Analysts expect GE HealthCare Technologies (GEHC) to earn $5.02 a share in FY26, the average of 13 estimates as of Nov 16, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice
FY26 consensus EPS
$5.02
13 analysts
FY27 consensus EPS
$5.53
13 analysts · low $5.15, high $5.77
EPS revisions, 31 days
+2.0%
$4.92 to $5.02
Disagreement, FY26
1.0%
high to low, $5.00 to $5.05

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 16, 2026 · we check it nightly

Analysts expect GE HealthCare Technologies to earn $7.53 a share in FY30, growing about 11% a year; 3 analysts publish an estimate for FY30.

Forward P/E · FY26E
16.5×
$82.96 (as of close, Nov 16, 2026) ÷ $5.02 consensus EPS
Coverage · FY26
13 · 16
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $5.02, up 2.0% in 90 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 90 days. One step per nightly change.

−0.4%+1.0%+2.4%FY26 +2.0%FY27 +1.7%Aug 18Nov 16
EPS30 days90 daysshown aboveSince Jul 2
FY2613 analysts▲ +2.0%$4.92 to $5.02▲ +2.0%$4.92 to $5.02▲ +2.9%$4.88 to $5.02
FY2713 analysts▲ +1.7%$5.43 to $5.53▲ +1.7%$5.43 to $5.53▲ +2.2%$5.40 to $5.53
Dec '2612 analysts▼ −2.4%$1.60 to $1.56▼ −2.6%$1.60 to $1.56▼ −2.6%$1.60 to $1.56
Mar '278 analysts24 of 30 days−0.8% so far24 of 90 days−0.8% so far▼ −0.8%$1.12 to $1.11

Contributors at both ends of the window: FY26 12 and 13. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 16, 2026 · consensus as of Nov 16, 2026

At 17.5 times earnings, which is what GE HealthCare Technologies trades at today, the FY27 consensus of $5.53 works out to $96 a share.

Consensus EPS · FY27
$5.53
13 analysts · low $5.15, high $5.77 · thin coverage
Multiple · today's trailing P/E
17.5×
$82.96 (as of close, Nov 16, 2026) ÷ $4.75, the last four reported quarters, including EPS computed by Tenet
×
Receipt · GEHC · FY27Nov 16, 2026
Implied, a share
$96

Range on the low and high estimate: $90 to $101.

$90 low$101 high
5.53 × 17.5, to the dollar
Drag the multipleShaded: where GE HealthCare Technologies' P/E sat at each fiscal year end, FY23 to FY25. Each dot is one year.
15×20×25×29×
today 17.5×10-yr median 18.0×5-yr avg 20.5×$96 a share

Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 16.5 times the FY26 consensus for earnings the Street expects to grow about 10% a year to FY28. That is 1.6 times the growth rate.Show today's multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY23 to FY25 · over 3 fiscal years. The mark is the median of the last 3.
17.5× today
18.0× low25.6× high
18.0× median
Forward 16.5× is a different measure, so it is not placed on a trailing record. Today's mark is the trailing 17.5×, on the same basis as every year behind it.

How much do analysts disagree?

For FY30, estimates run from $7.44 to $7.61 around an average of $7.53, drawn by 3 analysts.

FY26E13 analysts
$5.00 to $5.05 · 1.0%
FY27E13 analysts
$5.15 to $5.77 · 11.2%
FY28E9 analysts
$5.71 to $6.53 · 13.3%
FY29E3 analysts
$6.76 to $6.91 · 2.2%
FY30E3 analysts
$7.44 to $7.61 · 2.2%

The dashed line is FY25 filed $4.55, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect GE HealthCare Technologies to earn $1.56 a share in the December quarter, the average of 12 estimates. Results are expected by Feb 8, 2027. Last quarter, which ended in September, GE HealthCare Technologies earned $1.36 a share. Analysts had expected $1.20, so it came in 12.9% higher.

$1.28
$1.56high $1.58
low $1.54
+21.7%crosses bases
Dec 2025 quarterfiled · GAAPDec 2026 quarterconsensus · Street basis · 12 analysts
Expected report
Feb 8, 2027
Expected by Feb 8. An estimate, not a date the company has set. Companies move it.
Revenue expected · December quarter
$5,924.3M
11 analysts, 5,864.3 to 5,994.2 in $M · 5,698.0 in the same quarter a year ago

The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. For the March quarter, analysts expect $1.11 a share.

Does GE HealthCare Technologies usually beat or miss?

So far we have checked 10 quarters, of which 5 came in above the estimate we held. We add a quarter to this record each time GE HealthCare Technologies reports. The next report is expected by Feb 8, 2027.

We started recording estimates on Jul 2, 2026, so quarters that reported before that date cannot be checked.

Before our record
Dec '23
Our record, one quarter per report
−10.7%
Mar '24reaction
−14.3%
−4.8%
Jun '24reaction
+2.4%
−3.1%
Sep '24reaction
+2.3%
+25.1%
Dec '24reaction
+8.8%
+34.6%
Mar '25reaction
+3.3%
+15.5%
Jun '25reaction
−7.8%
−6.3%
Sep '25reaction
−2.5%
−8.5%
Dec '25reaction
+4.9%
Mar '26left out · adjusted
+20.0%
Jun '26reaction
−2.3%
+12.9%
Sep '26reaction
+6.6%
reportsFeb 8
Dec '26
Checked so far
10 quarters
one more every report
Beat expectations
5 of 10
full details on the Earnings tab
Share price reaction
+0.1%
the average over all 10 checked quarters, one session each, timed to each release
Typical gap vs estimate
+4.9%
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for GE HealthCare Technologies on Jul 2, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Mar '24, Jun '24, Sep '24, Dec '24, Mar '25, Jun '25, Sep '25, Dec '25 are drawn hollow: we hold no estimate for those quarters recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.

The Street expects sales to grow 4.9% in FY27 and EPS 10.0%. Sales are part of it: the net margin moves from 10.6% to 10.9%, and the implied share count from about 461M to 451M, so these numbers assume the count keeps falling.Show the decomposition and the margin ladderHide the decomposition
FY27 EPS growth, in points
Revenue growth+4.9
Net margin change+2.8
Share count change+2.3
EPS growth+10.0
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
13 analysts publish an EPS estimate for FY26 and 16 publish revenue. Coverage thins with distance: 3 EPS estimates for FY30. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
1613
FY26E
1413
FY27E
169
FY28E
143
FY29E
143
FY30E
The FY26 panel held 12 analysts when our record of it began on Jul 2, 2026 and holds 13 tonight.

The full consensus, year by year

Consensus as of Nov 16, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
182327historyStreet forecastFY22FY25FY30E

Coverage thins with distance: 16 revenue estimates for FY26, 14 for FY30.

Diluted EPS · $filed · consensus average · band = low to high
2.765.277.79historyStreet forecastFY22FY25FY30E

Out-year bands widen as fewer analysts publish: 13 EPS estimates for FY26, 3 for FY30.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed20.6—4.55————as filed17.5×
FY26E21.921.8 to 21.9▲6.0%a5.025.00 to 5.05▲10.4%a4.12.30.4616 · 1316.5×
FY27E22.922.8 to 23.1▲4.9%5.535.15 to 5.77▲10.0%4.42.50.4514 · 1315.0×
FY28E24.123.7 to 24.7▲5.0%6.135.71 to 6.53▲10.9%4.72.80.4516 · 913.5×
FY29E25.625.4 to 25.8▲6.3%6.846.76 to 6.91n/cb5.23.10.4614 · 312.1×
FY30E26.926.7 to 27.1▲5.0%7.537.44 to 7.61▲10.1%5.63.50.4614 · 311.0×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 13 EPS estimates for FY26, 16 for revenue. Not investment advice.

What do analysts expect GE HealthCare Technologies to earn in FY26?

Analysts expect GE HealthCare Technologies to earn $5.02 a share in FY26, the average of 13 estimates as of Nov 16, 2026.

What is GE HealthCare Technologies' earnings forecast for FY27?

The FY27 consensus for GE HealthCare Technologies is $5.53 a share from 13 analysts, with a low of $5.15 and a high of $5.77, as of Nov 16, 2026.

Have analysts raised GE HealthCare Technologies' earnings estimates?

GE HealthCare Technologies' FY26 EPS consensus rose 2.0% in 90 days, from $4.92 to $5.02, as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.